Clinical trial Recruiting at 2 sites Phase 4 Interventional Ages 18 and up

Using Dexmedetomidine and Esketamine to Reduce Bladder Discomfort from Catheters

Official title: Effect of Dexmedetomidine and Esketamine on Catheter-related Bladder Discomfort in Patients Undergoing Transurethral Surgery: a 2 x 2 Factorial Randomized Trial

Run by Peking University First Hospital · NCT06399185 · Data updated 2026-11-12

This study is testing if the combination of two medications, dexmedetomidine and esketamine, can help reduce bladder discomfort caused by catheters in patients having urological surgery.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1740 (estimated)
SponsorPeking University First Hospital
Academic / other
Locations2 sites (Beijing, Beijing Municipality and 1 other locations)
StatusRecruiting
StartedJune 6, 2024
Main results expectedApril 2027
Study endsMay 2027
Registry record updatedJuly 31, 2025
Trial IDNCT06399185 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older scheduled for transurethral bladder or prostate surgery requiring a urinary catheter.

Probably not a fit

Patients with chronic urinary catheters or those with certain pre-existing medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of dexmedetomidine and esketamine on catheter-related bladder discomfort (CRBD) in patients undergoing transurethral urological surgery. It employs a 2x2 factorial design to assess the efficacy of these medications, both individually and in combination, in reducing the incidence of CRBD after surgery. The study aims to improve patient comfort and satisfaction by potentially decreasing the pain and discomfort associated with urinary catheters post-anesthesia. Participants will be monitored for CRBD symptoms and overall recovery outcomes.

Why it matters

Potential benefit: If successful, this study could significantly enhance patient comfort and satisfaction during the postoperative period by reducing catheter-related bladder discomfort.

How similar studies have gone: Previous studies have shown promising results with similar approaches using dexmedetomidine and esketamine for pain management, indicating potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 18 years or above;
* Scheduled to undergo transurethral bladder or prostate surgery (including transurethral resection of bladder tumor, transurethral resection of prostate, and transurethral thulium laser prostatectomy) under general anesthesia;
* Required postoperative retention of a three-chamber urinary catheter.

Exclusion Criteria:

* Indwelling urinary catheters or chronic analgesic therapy for ≥1 month before surgery;
* Uncontrolled hypertension before surgery (resting ward systolic pressure \>180 mmHg or diastolic pressure \>110 mmHg);
* Severe bradycardia (heart rate ≤50 beats per minute), sick sinus syndrome, or atrioventricular block of degree II or above without pacemaker, or having myocardial infarction, severe heart insufficiency (New York Heart Association class ≥3), or tachyarrhythmia within a year;
* Preoperative history of schizophrenia, epilepsy, Parkinson's disease, myasthenia gravis, or intracranial hypertension;
* Preoperative history of hyperthyroidism and pheochromocytoma;
* Inability to communicate due to coma, severe dementia, or language barrier before surgery;
* Severe liver dysfunction (Child-Pugh grade C), severe renal dysfunction (receiving dialysis before surgery), or Amercian Society of Anesthesiologists classification ≥IV;
* Scheduled admission to the intensive care unit with endotracheal intubation after surgery;
* Other conditions that are considered unsuitable for study participation.

Where it's running

  • Peking University First Hospital
    Beijing, Beijing Municipality, China
    Recruiting
  • Peking University Shenzhen Hospital
    Shenzhen, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.